Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Teva
Baxter
Covington
Fish and Richardson
Cantor Fitzgerald
Colorcon
Accenture
US Department of Justice

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 060734

« Back to Dashboard

NDA 060734 describes BACIGUENT, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional details are available on the BACIGUENT profile page.

The generic ingredient in BACIGUENT is bacitracin. There are twenty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bacitracin profile page.
Summary for 060734
Tradename:BACIGUENT
Applicant:Pharmacia And Upjohn
Ingredient:bacitracin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 060734

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:OINTMENT;OPHTHALMICStrength500 UNITS/GM
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Cipla
Boehringer Ingelheim
Chinese Patent Office
US Army
Fuji
QuintilesIMS
Citi
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.